Release Date: 01/02/18 08:09 Summary: Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 2.71MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%